BioCentury
ARTICLE | Company News

Avidis SA, Merck, sanofi-aventis deal

December 5, 2005 8:00 AM UTC

Merial Ltd., a JV between MRK and SAN, received rights to use Avidis' aXent, an adjuvant-free immunization technology, to develop two recombinant vaccines for infectious diseases in animals. Further t...